EditorialColette Dong, co-founder of a New York bouncing studio called The Ness, does a trampoline workout at the studio on Oct. 27, 2022. (Angelo Silvio/The New York Times)
EditorialAlong with colleagues, Dr. Joseph Wu, director of the Stanford Cardiovascular Institute, is using CRISPR to draw links between the DNA of individual patients and heart disease. (Nina Riggio/The New York Times)
EditorialMany doctors recommend a coronary calcium scan to pinpoint which patients would benefit from treatment to reduce their cardiovascular risk. (Rachel Levit/The New York Times)
EditorialPaul McAlvain recovers in the cardiovascular intensive care unit at OHSU Hospital in Portland, Ore., after his surgery, which was moved from Sept. 1 to Sept. 8 because of a spike in COVID-19 cases.?(Alisha Jucevic/The New York Times)
EditorialPaul McAlvain recovers in the cardiovascular intensive care unit at OHSU Hospital in Portland, Ore., after his surgery, which was moved from Sept. 1 to Sept. 8 because of a spike in COVID-19 cases.?(Alisha Jucevic/The New York Times)
EditorialDr. Erik Eddie Suarez, center, a cardiovascular surgeon at Houston Methodist Hospital, was among those who faced impossible choices about whether to put patients on ECMO. (Erin Schaff/The New York Times)
EditorialClockwise from top left: Kimberly Brown, an emergency room doctor in Memphis, Tenn. (Andrea Morales/The New York Times); Pooja Pundhir, a hospitalist in Houston. (Michael Starghill Jr./The New York Times); Anna Maria Ruiz, an intensive care unit nurse in Austin, Texas. (Tamir Kalifa/The New York Times); Lillie Lodge, a cardiovascular nurse in Raleigh, N.C. (Veasey Conway/The New York Times); Zola Nlandu, an internal medicine doctor and infectious disease fellow in Tampa, Fla. (Eve Edelheit/The New York Times); Melhim Bou Alwan, a hospitalist in Atlanta. (Kevin D. Liles/The New York Times)
Loading